These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 15553066

  • 1. [Treatment strategies of acute and chronic hepatitis C].
    Gładysz A, Inglot M.
    Przegl Epidemiol; 2002; 56 Suppl 5():10-5. PubMed ID: 15553066
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Genotype 1 superresponder treat for only 24 weeks].
    MMW Fortschr Med; 2005 Dec 15; 147(51-52):69. PubMed ID: 16402717
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treating hepatitis C: are children the same as adults?
    Delgado-Borrego A.
    Gastroenterology; 2011 Feb 15; 140(2):389-92. PubMed ID: 21172331
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment options for patients with chronic hepatitis C not responding to initial antiviral therapy.
    Jacobson IM.
    Clin Gastroenterol Hepatol; 2009 Sep 15; 7(9):921-30. PubMed ID: 19362605
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatitis C treatment, HAART and side effects.
    TreatmentUpdate; 2001 Sep 15; 13(7):7-8. PubMed ID: 11794865
    [No Abstract] [Full Text] [Related]

  • 13. Peginterferon and ribavirin for hepatitis C.
    Abramowicz M.
    N Engl J Med; 2007 Mar 22; 356(12):1270-1; author reply 1271. PubMed ID: 17378100
    [No Abstract] [Full Text] [Related]

  • 14. Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!".
    Baiocchi L, Lenci I, Carbone M, Angelico M.
    Hepatology; 2009 Nov 22; 50(5):1676-7. PubMed ID: 19876945
    [No Abstract] [Full Text] [Related]

  • 15. [Eliminating the gray zone. What can be done in normal ALT values?].
    MMW Fortschr Med; 2004 Apr 26; 146 Spec No 1():75. PubMed ID: 15373059
    [No Abstract] [Full Text] [Related]

  • 16. Interferon for hepatitis C patients with psychiatric disorders.
    Rifai MA, Bozorg B, Rosenstein DL.
    Am J Psychiatry; 2004 Dec 26; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919
    [No Abstract] [Full Text] [Related]

  • 17. Pegylated IFNs for chronic hepatitis C: an update.
    Grace MJ, Cutler DL, Bordens RW.
    Expert Opin Drug Deliv; 2005 Mar 26; 2(2):219-26. PubMed ID: 16296749
    [Abstract] [Full Text] [Related]

  • 18. A success story with chronic hepatitis C.
    Weekley D, Yuen JC.
    J Ark Med Soc; 2005 Dec 26; 102(6):158-9. PubMed ID: 16381402
    [No Abstract] [Full Text] [Related]

  • 19. Digestive Disease Week 2000 conference report: New treatments for chronic hepatitis C.
    Brown PJ, Neuman MG.
    Can J Clin Pharmacol; 2001 Dec 26; 8(2):67-71. PubMed ID: 11493933
    [Abstract] [Full Text] [Related]

  • 20. Vitiligo improvement in a hepatitis C patient after treatment with PEG-interferon alpha-2a and ribavirin: a case report.
    Taffaro M, Pyrsopoulos N, Cedron H, Cacayorin E, Weppler D, Moon J, Nishida S, Levi D, Kato T, Selvaggi G, Tzakis A, Schiff E.
    Dig Dis Sci; 2007 Dec 26; 52(12):3435-7. PubMed ID: 17431776
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.